Presentation TCT 2014 Anatomic Criteria for the MitraClip: Are the Everest Criteria Just a Start? Presenter: Olaf Franzen, James B. Hermiller Jr, Michael J. Rinaldi, Saibal Kar September 13, 2014
Presentation TCT 2014 TCT 789: Symptomatic Improvement with MitraClip Therapy for Prohibitively High-Risk DMR Patients Presenter: Olaf Franzen, James B. Hermiller Jr, Michael J. Rinaldi, Brij Maini September 13, 2014
Presentation TCT 2014 Heart Team Decisions: Who Is the Appropriate Prohibitive-Risk DMR Patient for MitraClip? Presenter: Olaf Franzen, James B. Hermiller Jr, Michael J. Rinaldi, Gorav Ailawadi September 13, 2014
Presentation TCT 2014 TCT 807: Multislice Computed Tomography Procedural Planning for Transcatheter Mitral Annuloplasty Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Jovana Pavicevic September 13, 2014
Presentation TCT 2014 Beyond TEE 2: CT, MRI, and Image Fusion Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Jonathon A. Leipsic September 13, 2014
Presentation TCT 2014 Beyond TEE 1: ICE Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Brij Maini September 13, 2014
Presentation TCT 2014 Role of Exercise and Viability in the Evaluation of Mitral Regurgitation Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Maurice E. Sarano September 13, 2014
Presentation TCT 2014 Echocardiography of Mitral Regurgitation: A Critical Appraisal of Quantification and Prognostic Impact Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim September 13, 2014
Presentation TCT 2014 Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Gregg W. Stone September 13, 2014
Presentation TCT 2014 Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)? Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Robert O. Bonow September 13, 2014
Presentation TCT 2014 TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Saibal Kar September 13, 2014
Presentation TCT 2014 Just How Effective Is Biventricular Pacing for Functional Mitral Regurgitation? Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Anita Asgar September 13, 2014
Presentation TCT 2014 Prognosis of Secondary MR in Heart Failure: New Insights from the Italian Registry Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Francesco Maisano September 13, 2014
Presentation TCT 2014 Primary vs Secondary Mitral Regurgitation: Two Different Diseases with Different Etiologies, Prognostic Impact, and Therapies Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Jeffrey S. Borer September 13, 2014
Presentation TCT 2014 Mitralign: Percutaneous Annuloplasty for Tricuspid Regurgitation Presenter: Alec S. Vahanian, Scott Lim September 13, 2014
Presentation TCT 2014 Cardiologist's Perspective: How I Use the Anatomical and Hemodynamic Data in MitraClip Clinical Decision Making Presenter: Thomas H. Maloney, John R. Zimmerman, Michael J. Rinaldi September 13, 2014
Presentation TCT 2014 Hemodynamics of Mitral Regurgitation and Live Calculations Using the Telestrator Presenter: Thomas H. Maloney, John R. Zimmerman, Jeff Davis September 13, 2014
Presentation TCT 2014 Fundamental Knowledge: Mitral Valve Anatomy, Function, and Relational Pathology Presenter: Thomas H. Maloney, John R. Zimmerman, Kenneth A. Gorski September 13, 2014
News Conference News TCT 2014 PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients Yael L. Maxwell September 13, 2014
News Conference News TCT 2014 Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk September 13, 2014